Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 79, Issue 3
Volume 79, Issue 3
15 September 2024
ISSN 1058-4838
EISSN 1537-6591

Volume 79, Issue 3, 15 September 2024

In the Literature

Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages i–iii, https://doi.org/10.1093/cid/ciae409

State-of-the-Art Review

Said El Zein and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 581–582, https://doi.org/10.1093/cid/ciae397

Voices of ID

Simone Blaser
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 583–584, https://doi.org/10.1093/cid/ciae091

Invited Commentary

Alexander S Rabin and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 585–587, https://doi.org/10.1093/cid/ciae276

Antimicrobial Resistance and Stewardship

Daniel J Livorsi and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 588–595, https://doi.org/10.1093/cid/ciae224

We developed a model using electronically available data to predict antibiotics prescribed at hospital discharge. A risk-adjusted metric based on this model showed that some hospitals are more successful in reducing antibiotic overuse at this transition of care.

Jacopo Angelini and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 596–599, https://doi.org/10.1093/cid/ciae178
Sonali D Advani and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 600–603, https://doi.org/10.1093/cid/ciae230

Bacterial Infections

Clark D Russell and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 604–611, https://doi.org/10.1093/cid/ciae281

We found no overall association between metastatic complications (predominantly musculoskeletal) and death due to Staphylococcus aureus bacteraemia. Each endpoint was associated with distinct host, clinical and microbiologic features. Age and multi-morbidity were associated with death but not metastatic infection.

Torgny Sunnerhagen and Magnus Rasmussen
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 612–614, https://doi.org/10.1093/cid/ciae223

Clinical Trials

Karen C Tran and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 615–625, https://doi.org/10.1093/cid/ciae306

Angiotensin receptor blockers (ARBs) should not be used for the treatment of acute COVID-19 infections due to safety concerns. ARBs should be used cautiously in patients hospitalized with pneumonia.

Keerthi Anpalagan and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 626–634, https://doi.org/10.1093/cid/ciae289

This article reports the protocol for the adjunctive treatment domain of the Staphylococcus aureus Network Adaptive Platform (SNAP) trial. The adjunctive treatment domain aims to test the effectiveness of adjunctive clindamycin in patients with Staphylococcus aureus bacteremia.

COVID-19/SARS CoV-2

James S Andrews and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 635–642, https://doi.org/10.1093/cid/ciae205

While the primary endpoint of the study was not significant, the data suggest eliminating latent viral RNA by increasing serum RNase activity may improve fatigue in patients with post-acute sequelae of SARS-CoV-2. Women may respond better to this approach than men.

Lei Yan and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 643–651, https://doi.org/10.1093/cid/ciae202

Nirmatrelvir-ritonavir was associated with reductions in 30-day hospitalizations and deaths in older veterans, those at highest predicted risk for severe outcomes, and immunocompromised groups. Benefit was not observed in younger veterans or groups at lower predicted risk for hospitalization and death.

Trevor S Johnston and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 652–655, https://doi.org/10.1093/cid/ciae279

Emerging Infections

Mayara Secco Torres Silva and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 656–659, https://doi.org/10.1093/cid/ciae290
Erica Telford and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 660–662, https://doi.org/10.1093/cid/ciae292

Endovascular Infections

David Alonso-Menchén and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 663–671, https://doi.org/10.1093/cid/ciae334

This study describes the clinical features and prognosis of Cutibacterium spp. valvular and cardiac device–related infective endocarditis in a nationwide prospective cohort over a 16-year period and examines the impact of molecular techniques and the new Duke-ISCVID criteria on diagnosis.

Fungal Infections

Alex Soriano and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 672–681, https://doi.org/10.1093/cid/ciae363

This preplanned subgroup analysis of the ReSTORE trial supports rezafungin efficacy and safety versus caspofungin for the treatment of candidemia and/or invasive candidiasis in patients with a positive culture close to randomization, who may represent patients with more serious infections.

Emmanuel Dudoignon and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 682–689, https://doi.org/10.1093/cid/ciae337

Independent risk factors for invasive fungal diseases (IFDs) are indoor burn, deep burn surface area, and severity score. IFD is independently associated with a risk of death.

Hepatitis

Wei-Ju Su and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 690–700, https://doi.org/10.1093/cid/ciae176

Our study provides real-world evidence concerning the implementation and impact of mother-to-child hepatitis B prevention programs using infant–mother pairs to assess hepatitis B surface antigen prevalence, including maternal antiviral prophylaxis as the standard of care.

John M Cafardi and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 701–704, https://doi.org/10.1093/cid/ciae177
Helen L Zhang and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 705–708, https://doi.org/10.1093/cid/ciae241

HIV/AIDs

Edward R Cachay and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 709–716, https://doi.org/10.1093/cid/ciae124

People with human immunodeficiency virus with both cytological anal high-grade squamous intraepithelial lesion and nadir CD4 cell count ≤200/µL face 13-fold increased anal cancer risk compared with those lacking both. Anal cancer mortality (21%) occurred exclusively among stage IIIA patients.

Carlos S Saldana and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 717–726, https://doi.org/10.1093/cid/ciae100

We applied machine learning to predict HIV incidence in a high-incidence US county using deidentified public health data, focusing on sociodemographic factors and sexually transmitted infections. The models showed high accuracy, suggesting the potential for guiding public health strategies.

Jennifer Jao and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 727–733, https://doi.org/10.1093/cid/ciae088

In utero human immunodeficiency virus (HIV) and antiretroviral (ARV) exposure is associated with lower insulin sensitivity through the first 36 months of life, indicating metabolic disturbances and potentiallly poorer metabolic health later in life for children with perinatal HIV/ARV exposure.

Pediatric and Maternal Infectious Diseases

Sophie C H Wen and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 734–743, https://doi.org/10.1093/cid/ciae341

A total of 931 gram-negative bloodstream infection episodes involving 818 children were studied. The children were typically young and medically complex. Enterobacterales comprised 71%, of which 22% demonstrated third-generation cephalosporin resistance. Bloodstream infections caused by Enterobacterales resistant to third-generation cephalosporin were associated with worse outcomes.

Elizabeth Daniels and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 744–750, https://doi.org/10.1093/cid/ciae260

Congenital syphilis pregnancy outcomes in Missouri are strongly associated with inadequate prenatal care, substance use, housing instability, and interactions with the justice system. Future studies should evaluate the role of social support in prevention and management of congenital syphilis.

Respiratory Infections

Brooke A Jarrett and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 751–760, https://doi.org/10.1093/cid/ciae268

This cluster-randomized trial demonstrated that integrating QuantiFERON Gold In-Tube testing into routine HIV care led to substantially higher testing and preventive treatment for tuberculosis infection than the standard of care. This trial was conducted in South Africa with 2232 patients in the analysis.

Sara Ruth Kim and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 761–771, https://doi.org/10.1093/cid/ciae216

In pediatric myeloablative allogeneic hematopoietic cell transplantation recipients, pretransplant symptomatic upper respiratory tract infections, including human rhinovirus virus, is associated with increased duration of hospitalization after transplant in univariable models.

Photo Quiz

Wenting Hu and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 772–774, https://doi.org/10.1093/cid/ciae225
Brian P Epling and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 775–777, https://doi.org/10.1093/cid/ciae179

Viral Infections

Ian McGovern and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 778–786, https://doi.org/10.1093/cid/ciae180

Changes in influenza incidence generally occur gradually as individuals age, with increases in hospitalization incidence beginning around 50 years of age. Influenza infections frequently result in serious secondary complications such as pneumonia and are associated with frequent antibiotic and antiviral prescriptions.

Per Ljungman and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 787–794, https://doi.org/10.1093/cid/ciae321

The existing definitions of cytomegalovirus (CMV) infection and disease for use in clinical trials have been updated. The update is based on new developments including the introduction of clinically significant CMV infection and developments in diagnosis of CMV disease.

Jennifer M Cuellar-Rodriguez and David van Duin
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 795–796, https://doi.org/10.1093/cid/ciae319

Correspondence

John C Christenson and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Page 797, https://doi.org/10.1093/cid/ciad790
Dallas J Smith and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 797–798, https://doi.org/10.1093/cid/ciad795
Emmanuel Lafont and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 798–800, https://doi.org/10.1093/cid/ciad785
George Sakoulas and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 800–801, https://doi.org/10.1093/cid/ciae080
Rochelle P Walensky and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages 801–802, https://doi.org/10.1093/cid/ciae038

Correction

Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Page 803, https://doi.org/10.1093/cid/ciae356

State-of-the-Art Review

Said El Zein and others
Clinical Infectious Diseases, Volume 79, Issue 3, 15 September 2024, Pages e11–e26, https://doi.org/10.1093/cid/ciae394

This article explores the management of pelvic osteomyelitis in patients with stage IV pressure injuries, emphasizing the need for multidisciplinary care and highlighting the challenges faced by healthcare providers due to the lack of high-quality evidence to guide best practices.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close